These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 15119048)

  • 21. "In vivo" and "in vitro": tests in the diagnosis of trichophyton allergy.
    Palma-Carlos ML; Palma-Carlos AG
    Eur Ann Allergy Clin Immunol; 2007 Dec; 39(10):328-32. PubMed ID: 18386433
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Production of monoclonal antibodies specific for native equine IgE and their application to monitor total serum IgE responses in Icelandic and non-Icelandic horses with insect bite dermal hypersensitivity.
    Wilson AD; Harwood L; Torsteinsdottir S; Marti E
    Vet Immunol Immunopathol; 2006 Aug; 112(3-4):156-70. PubMed ID: 16574245
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Home therapy with subcutaneous anti-immunoglobulin-E antibody omalizumab in 25 patients with immunoglobulin-E-mediated (allergic) asthma.
    Liebhaber M; Dyer Z
    J Asthma; 2007 Apr; 44(3):195-6. PubMed ID: 17454337
    [No Abstract]   [Full Text] [Related]  

  • 24. Immunoglobulin E: role in asthma and allergic disease: lessons from the clinic.
    Owen CE
    Pharmacol Ther; 2007 Jan; 113(1):121-33. PubMed ID: 17000005
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Omalizumab, an anti-IgE monoclonal antibody to treat severe asthma].
    Michils A; Sternon J
    Rev Med Brux; 2006; 27(3):167-72. PubMed ID: 16894955
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Anti-immunoglobulin E treatment with omalizumab in allergic diseases: an update on anti-inflammatory activity and clinical efficacy.
    Holgate ST; Djukanović R; Casale T; Bousquet J
    Clin Exp Allergy; 2005 Apr; 35(4):408-16. PubMed ID: 15836747
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prospects for the clinical control of IgE synthesis.
    Katz DH
    Prog Clin Immunol; 1980; 4():127-50. PubMed ID: 6992217
    [No Abstract]   [Full Text] [Related]  

  • 28. [Contribution of molecular biology to allergology practice].
    Pauli G; Metz-Favre C
    Rev Prat; 2008 Jan; 58(2):129-35. PubMed ID: 18361272
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Monoclonal antibody therapy and viral infections: update and beyond.
    Antonelli G
    Clin Microbiol Infect; 2011 Dec; 17(12):1757-8. PubMed ID: 22010631
    [No Abstract]   [Full Text] [Related]  

  • 30. The anti-inflammatory effects of omalizumab confirm the central role of IgE in allergic inflammation.
    Holgate S; Casale T; Wenzel S; Bousquet J; Deniz Y; Reisner C
    J Allergy Clin Immunol; 2005 Mar; 115(3):459-65. PubMed ID: 15753888
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Anti-IgE therapy--possible way in severe nut allergy. The hidden allergen in candy is a danger for risk groups].
    Hedlin G; Foucard T
    Lakartidningen; 2003 Apr; 100(15):1314-5. PubMed ID: 12739399
    [No Abstract]   [Full Text] [Related]  

  • 32. Novel IgE peptide-based vaccine prevents the increase of IgE and down-regulates elevated IgE in rodents.
    Peng Z; Liu Q; Wang Q; Rector E; Ma Y; Warrington R
    Clin Exp Allergy; 2007 Jul; 37(7):1040-8. PubMed ID: 17581197
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immunotherapy for hymenoptera venom hypersensitivity.
    Müller U; Golden DB; Lockey RF; Shin B
    Clin Allergy Immunol; 2008; 21():377-92. PubMed ID: 18828518
    [No Abstract]   [Full Text] [Related]  

  • 34. Immunotherapy for allergic diseases.
    Eisen AH
    Can Med Assoc J; 1973 Aug; 109(3):167-8. PubMed ID: 4728944
    [No Abstract]   [Full Text] [Related]  

  • 35. [Omalizumab, an anti-IgE monoclonal antibody to treat severe asthma].
    Michils A; Sternon J
    J Pharm Belg; 2006; 61(3):83-7. PubMed ID: 17058881
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Adverse effects and fatalities associated with subcutaneous allergen immunotherapy.
    Bukantz SC; Bagg AS; Lockey RF
    Clin Allergy Immunol; 2008; 21():455-68. PubMed ID: 18828523
    [No Abstract]   [Full Text] [Related]  

  • 37. Immunotherapy of allergic diseases: a forthcoming therapy.
    Saint-Remy JM
    Acta Clin Belg; 1989; 44(6):369-76. PubMed ID: 2698038
    [No Abstract]   [Full Text] [Related]  

  • 38. Allergen skin tests and free IgE levels during reduction and cessation of omalizumab therapy.
    Corren J; Shapiro G; Reimann J; Deniz Y; Wong D; Adelman D; Togias A
    J Allergy Clin Immunol; 2008 Feb; 121(2):506-11. PubMed ID: 18269927
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Immunoglobulins, immune complexes and precipitins in allergic diseases].
    Ortega Gómez H
    Alergia; 1984; 31(2):57-62. PubMed ID: 6383108
    [No Abstract]   [Full Text] [Related]  

  • 40. [Allergic disease treatments: classic and innovative therapeutics].
    Têtu L; Didier A
    Rev Prat; 2007 Jun; 57(12):1339-48. PubMed ID: 17717947
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.